Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  arsenic trioxide
Find trials that include:  Any drugs shown
Results 1-3 of 3 for your search:
Start Over
Tretinoin and Arsenic Trioxide in Treating Patients with Untreated Acute Promyelocytic Leukemia
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Age: 12 to 21
Trial IDs: AAML1331, NCI-2014-02266, PAAML1331_A01PAMDREVW0, NCT02339740
Tretinoin and Arsenic Trioxide with or without Gemtuzumab Ozogamicin in Treating Patients with Previously Untreated Acute Myeloid Leukemia
Phase: Phase II
Type: Treatment
Age: 10 and over
Trial IDs: 2010-0981, NCI-2011-02767, NCT01409161
Arsenic Trioxide and Imatinib Mesylate, Dasatinib, or Nilotinib in Treating Patients with Chronic Myelogenous Leukemia
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 11-107, NCI-2011-03292, NCT01397734
Start Over